Evidence map›Paper›PMID 41281992›Full record

ArticleFrontiers in medicine2025

Fever duration, peak temperature and associated symptoms in Chinese adults with SARS-CoV-2 infection: a cross-sectional study.

Yang Ye, Xiyan Xin, Xinying Du, Yunjing Bai, Hongbo Shen

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yang Ye *Department of Traditional Chinese Medicine, Peking University Third Hospital, Beijing, China.
Xiyan Xin *Department of Traditional Chinese Medicine, Peking University Third Hospital, Beijing, China.
Xinying DuDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing, China.
Yunjing BaiDepartment of Rheumatism and Immunology, Seventh Medical Center of PLA General Hospital, Beijing, China.
Hongbo ShenDepartment of Traditional Chinese Medicine, Peking University Third Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Although the COVID-19 pandemic has passed, we still lack a comprehensive understanding of its fever-related characteristics. This study aims to elucidate the unique fever characteristics exhibited by Chinese SARS-CoV-2 patients, providing insights into the fever patterns of COVID-19 and enhancing our understanding of fever caused by viral infections. Methods: A descriptive study was conducted using an online questionnaire administered through a web-based survey platform from December 19, 2022, to January 5, 2023. Data pertaining to the demographic features and fever dynamics of SARS-CoV-2-infected individuals were collected and analyzed. Results: The study cohort consisted of 555 adult individuals presenting with fever, comprising 157 males (28.3%) and 398 females (71.7%), with a mean age of 39.8 ± 12.7 years. The average duration of fever was 2.5 ± 1.6 days, with a peak temperature recorded at 38.7 ± 0.7 °C. Notably, a negative correlation was discerned between peak fever temperature and age, while in female participants, fever duration displayed a positive correlation with age. Patients with underlying comorbidities, particularly those with lupus erythematosus, exhibited lower peak temperatures. Predominant symptoms reported during febrile episodes encompassed headache, cough, general malaise, and myalgia, while post-fever symptoms predominantly comprised cough, sputum production, nasal obstruction, and sore throat. Conclusion: Age may be an important factor influencing both the duration of fever and peak body temperature in SARS-CoV-2 infected individuals, while gender-specific variations appear to be limited. COVID-19 patients demonstrated noticeable heterogeneity in symptom manifestations both during the febrile phase and after fever resolution.

Indexed as

agecross-sectional surveyfevergenderSARS-CoV-2

Identifiers

PMID41281992
PMCPMC12631222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.